Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medizone/OTC: MZEI (AIDS and Hepatitis B Treatment) -- Ignore unavailable to you. Want to Upgrade?

To: gtoland who wrote (771)	5/31/2000 7:46:00 PM
From: gtoland	Read Replies (1) \| Respond to of 783

Now this is getting better for us. They expect for their treatments to be used on .02 (583,200) of the 300 million people affected with Hep C world wide. Anticipated (very conservative) profits for: 4th quarter 2001 $9.36 million revenue 1st quarter 2002 $51.66 million revenue 2nd quarter 2002 $75.96 million revenue 3rd quarter 2002 $100.26 million revenue 4th quarter 2002 $124.56 million revenue Year end sales 2002 Generator Sales $90.000,000 Cartridge Sales $262,440,000 Is this a penny stock company????? More later Gary